Browsing Tag
Lupin
81 posts
Lupin rolls out Darunavir Tablets, generic of Prezista in US
Lupin, an Indian pharmaceutical company, has announced the launch of Darunavir Tablets, available in 600mg and 800mg variants…
June 3, 2023
Lupin receives FDA approval for seizures medication Diazepam Rectal Gel
Lupin announced that its subsidiary Novel Laboratories has received approval from the US Food and Drug Administration (FDA)…
June 3, 2023
Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories,…
May 31, 2023
Lupin gets Health Canada approval for generic Spiriva for COPD treatment
Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to…
May 27, 2023
Lupin launches satellite laboratory in Vijayawada to expand diagnostics network
Indian healthcare company Lupin has announced the establishment of a satellite laboratory in Vijayawada, Andhra Pradesh, as part…
May 26, 2023
Lupin to acquire French generics injectables developer Medisol
Indian pharma company Lupin has agreed to acquire Medisol, a French pharmaceutical company, for an undisclosed price. Established…
May 6, 2023
Lupin expands diagnostics network with Bengaluru regional reference lab
Lupin Diagnostics, a subsidiary of Indian pharma company Lupin, has opened its new regional reference laboratory in Bengaluru…
April 16, 2023
Lupin bags tentative approval for Ocaliva Tablets generic in US
Lupin said that it has been issued tentative approval for Obeticholic Acid Tablets, 5 mg and 10 mg…
March 24, 2023
Can Lupin’s partnership with Caplin Steriles strengthen its position in the US injectable anesthetic market?
Lupin and Caplin Steriles secure FDA approval for generic Rocuronium Bromide Injection, targeting a $53M US anesthesia market segment.
March 21, 2023
FDA concludes inspection at Lupin Bioresearch Centre in Pune
Lupin said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s bioresearch…
March 13, 2023